Skip to content
10-K

Annual Report

Pulmonx Corp LUNG

0001127537-25-000012

← back to feed
Filed
Feb 25, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 14, 2025 39.8M sh
Shares Diluted FY 2024 · Dec 31, 2023 37.97M sh
Capex FY 2024 · Dec 31, 2023 $807K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$37.61M
Long Term Debt FY 2024 · Dec 31, 2023 $35.09M
Short Term Debt FY 2024 · Dec 31, 2023 $2.16M
Cash And Equivalents FY 2024 · Dec 31, 2023 $83.55M
Current Liabilities FY 2024 · Dec 31, 2023 $23.16M
Total Liabilities FY 2024 · Dec 31, 2023 $59.47M
Current Assets FY 2024 · Dec 31, 2023 $150.42M
Total Assets FY 2024 · Dec 31, 2023 $177.78M
Eps Diluted FY 2024 · Dec 31, 2023 −$1.60
Eps Basic FY 2024 · Dec 31, 2023 −$1.60
Sga Expense FY 2024 · Dec 31, 2023 $94.61M
Rd Expense FY 2024 · Dec 31, 2023 $18.08M
Net Income FY 2024 · Dec 31, 2023 −$60.84M
Operating Income FY 2024 · Dec 31, 2023 −$61.94M
Gross Profit FY 2024 · Dec 31, 2023 $50.75M
Cost Of Revenue FY 2024 · Dec 31, 2023 $17.92M
Revenue FY 2024 · Dec 31, 2023 $68.68M
Stockholders Equity FY 2024 · Dec 31, 2022 $154.01M